Breadcrumb

Breadcrumbs

Press Releases

Press Releases

News, Events, Updates, Breakthroughs

Journalists may direct questions to mediainquiries@dsi.com. Or click here for direct contact information for Daiichi Sankyo U.S. Public Affairs team

Press announcements are archived by release date, searchable by topic:

From To
Date Title
Mon Mar 06 00:00:00 GMT-04:00 2017
Daiichi Sankyo, Inc. Initiates ENTRUST-AF PCI Study Investigating Once-Daily SAVAYSA® (edoxaban) in ...
PDF (297 KB)
Fri Feb 17 00:00:00 GMT-04:00 2017
Daiichi Sankyo and ArQule Announce the Completion of the METIV-HCC Phase 3 Study of Tivantinib in S ...
PDF (190 KB)
Fri Feb 03 00:00:00 GMT-04:00 2017
Charleston Laboratories, Inc. and Daiichi Sankyo, Inc. Receive Complete Response Letter from FDA f ...
PDF (47 KB)
Wed Jan 18 00:00:00 GMT-04:00 2017
Daiichi Sankyo Initiates Phase 1/2 Study of Novel Antibody Drug Conjugate U3-1402 in Patients with ...
PDF (178 KB)
Mon Dec 12 00:00:00 GMT-04:00 2016
Daiichi Sankyo and DarwinHealth Announce Strategic Partnership to Deploy a Quantitative Systems Bio ...
PDF (163 KB)
Mon Dec 05 00:00:00 GMT-04:00 2016
Daiichi Sankyo Presents Phase 1 Data for MDM2 Inhibitor DS-3032 in Acute Myeloid Leukemia and Myelo ...
PDF (193 KB)
Thu Dec 01 00:00:00 GMT-04:00 2016
U.S. FDA Grants Fast Track Designation for HER2-Targeting Antibody Drug Conjugate DS-8201 for HER2- ...
PDF (180 KB)
Wed Nov 30 00:00:00 GMT-04:00 2016
Daiichi Sankyo Highlights Clinical Data of Two Novel Hematological Agents at the 58th Annual Meetin ...
PDF (178 KB)
Mon Nov 07 00:00:00 GMT-04:00 2016
Daiichi Sankyo Announces New Subgroup Analyses of Once-Daily SAVAYSA® (edoxaban) in Patients with N ...
PDF (367 KB)
Showing 31 - 39 of 39 results.

Press Release More Stories

More Stories

Who We Are

As the U.S. subsidiary of a global pharmaceutical innovator, Daiichi Sankyo, Inc. draws on a rich heritage of innovation, integrity and accountability..

read more ...